Huntingtin suppression restores cognitive function in a mouse model of Huntington’s disease
Amber L. Southwell(University of Central Florida), Michael R. Hayden(Family Research Institute), Nicholas S. Caron(University of British Columbia), Hailey Findlay Black(Child and Family Research Institute), Lynn A. Raymond(University of British Columbia), Yuanyun Xie(University of British Columbia), Erika B. Villanueva(University of British Columbia), Michael E. Østergaard(Ionis Pharmaceuticals (United States)), Crystal N. Doty(University of British Columbia), Holly Kordasiewicz(University of British Columbia), Niels H. Skotte(University of British Columbia), Bethany Fitsimmons(Ionis Pharmaceuticals (United States)), C. Frank Bennett(Pennsylvania State University), Louisa Dal Cengio(Child and Family Research Institute), Punit P. Seth(Ionis Pharmaceuticals (United States)), Matthew P. Parsons(Memorial University of Newfoundland), Eric E. Swayze(Ionis Pharmaceuticals (United States)), Lisa M. Anderson(Child and Family Research Institute), Douglas R. Langbehn(University of Iowa Hospitals and Clinics)
Cited by 123
Related Papers
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
|Cell Metabolism|2006|2.1k
Huntington disease
|Nature Reviews Disease Primers|2015|1.6k
Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis
|Nature Genetics|2003|976